Oxis Turbuhaler (Formoterol Fumarate Dihydrate)

Formoterol fumarate dihydrate, the active ingredient in Oxis Turbuhaler, is a long‑acting β2‑adrenergic agonist (LABA) presented as an inhalation powder for oral inhalation use. It provides bronchodilation for patients with chronic obstructive pulmonary disease and asthma. GNH USA supplies Oxis Turbuhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxis Turbuhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Formoterol fumarate dihydrate is a bronchodilator that acts on the airway smooth muscle to improve airflow in chronic respiratory diseases.

- Asthma: improves symptom control and reduces the frequency of exacerbations. - Chronic obstructive pulmonary disease (COPD): enhances lung function and decreases rescue medication use. - Exercise‑induced bronchoconstriction: prevents airway narrowing during physical activity.

Formoterol may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Tremor: mild shaking  - Headache  - Throat irritation  - Cough  - Nasal congestion  - Palpitations 

Serious or Rare Side Effects: - Paradoxical bronchospasm: sudden worsening of breathing - Cardiac arrhythmias: irregular heart rhythm - Hypokalemia: low blood potassium levels - Severe allergic reactions: rash, swelling, anaphylaxis

When using Oxis Turbuhaler, patients should follow clinical guidelines and monitor for adverse effects.

- Assess : Regularly t         t t  t  t t t t t t t t t t t t t t t t t t t t t t t t t t t t t t ... -   g   t  t  d  g  t  g  g -  t  t -  d \n-  - Store   t  t -  g -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  - -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  ewline -  -  - """ -  -  -  -  -  - Store  -  t -  -  - "); -  - """

The     "    "